Literature DB >> 32871801

Preliminary Report: Asymmetric Crypt Fission in Biopsies from Patients With Ulcerative Colitis.

Carlos A Rubio1, Peter T Schmidt2.   

Abstract

BACKGROUND: Recently, we found crypts with asymmetric fission bordering ulcers in colectomy specimens from patients with ulcerative colitis (UC). Here, we report crypts with asymmetric fission found in biopsies from patients with UC. PATIENTS AND METHODS: Sections from endoscopic biopsies from five patients with UC were reviewed. The number of transected (cut-across) crypts in symmetric and asymmetric fission was assessed in sections from three biopsies in each patient.
RESULTS: A total of 89 crypts in fission were recorded in the 15 biopsies; 36 (40.4%) were in symmetric fission and the remaining 53 (59.6%) in asymmetric fission.
CONCLUSION: A high frequency of asymmetric crypts in fission was demonstrated in endoscopic biopsies from patients with UC. It is suggested that this previously unaddressed histological parameter is included in pathological descriptions of endoscopic biopsies from patients with UC. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Colon; asymmetric fission; crypt fission; morphology

Mesh:

Year:  2020        PMID: 32871801      PMCID: PMC7652456          DOI: 10.21873/invivo.12089

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  11 in total

Review 1.  Normal histology of the colon.

Authors:  D S Levine; R C Haggitt
Journal:  Am J Surg Pathol       Date:  1989-11       Impact factor: 6.394

Review 2.  Rectal biopsy in inflammatory bowel disease.

Authors:  B C Morson
Journal:  N Engl J Med       Date:  1972-12-28       Impact factor: 91.245

3.  NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane.

Authors:  Maria-Magdalena Georgescu; Gilbert Cote; Nitin Kumar Agarwal; Charles L White
Journal:  Neoplasia       Date:  2014-04       Impact factor: 5.715

4.  A quantitative method of estimating inflammation in the rectal mucosa. IV. Ulcerative colitis in remission.

Authors:  C A Rubio; C Johansson; A Uribe; Y Kock
Journal:  Scand J Gastroenterol       Date:  1984-06       Impact factor: 2.423

5.  Corrupted Colonic Crypts Bordering Regenerating Mucosal Ulcers in Ulcerative Colitis.

Authors:  Carlos A Rubio
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

6.  APC in the regulation of intestinal crypt fission.

Authors:  H S Wasan; H S Park; K C Liu; N K Mandir; A Winnett; P Sasieni; W F Bodmer; R A Goodlad; N A Wright
Journal:  J Pathol       Date:  1998-07       Impact factor: 7.996

7.  Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia.

Authors:  Simon J Leedham; Trevor A Graham; Dahmane Oukrif; Stuart A C McDonald; Manuel Rodriguez-Justo; Rebecca F Harrison; Neil A Shepherd; Marco R Novelli; Janusz A Z Jankowski; Nicholas A Wright
Journal:  Gastroenterology       Date:  2008-11-07       Impact factor: 22.682

8.  PTEN phosphatase-independent maintenance of glandular morphology in a predictive colorectal cancer model system.

Authors:  Ishaan C Jagan; Ravi K Deevi; Aliya Fatehullah; Rebecca Topley; Joshua Eves; Michael Stevenson; Maurice Loughrey; Kenneth Arthur; Frederick Charles Campbell
Journal:  Neoplasia       Date:  2013-11       Impact factor: 5.715

9.  Colon cryptogenesis: asymmetric budding.

Authors:  Chin Wee Tan; Yumiko Hirokawa; Bruce S Gardiner; David W Smith; Antony W Burgess
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

Review 10.  An APC:WNT Counter-Current-Like Mechanism Regulates Cell Division Along the Human Colonic Crypt Axis: A Mechanism That Explains How APC Mutations Induce Proliferative Abnormalities That Drive Colon Cancer Development.

Authors:  Bruce M Boman; Jeremy Z Fields
Journal:  Front Oncol       Date:  2013-11-07       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.